Results 11 to 20 of about 15,403 (196)
SOME ASPECTS OF THE LISINOPRIL USAGE IN ARTERIAL HYPERTENSION TREATMENT
Рациональная фармакотерапия в кардиологии, 2016 The evidence basis and advantages of the lisinopril usage in a clinical practice as antihypertensive drug are presented. Special attention is paid to organoprotective lisinopril effects and lisinopril implementation at special clinical conditions ...
N. A. Jaiani
doaj +3 more sources
Determination of lisinopril in pharmaceuticals by a kinetic spectrophotometric method [PDF]
Journal of the Serbian Chemical Society, 2012 A kinetic spectrophotometric method for determination of lisinopril in pharmaceuticals has been developed. The method is based on activator action of lisinopril on Cu(II) ions catalysing the oxidation of nile blue A with hydrogen peroxide in borate ...
Čakar Mira, Popović Gordana
doaj +3 more sources
CARDIOPROTECTIVE PROPERTIES OF LISINOPRIL: NEW POSSIBILITIES
Рациональная фармакотерапия в кардиологии, 2018 Aim. To study the changes in the stiffness of the arterial wall, vasomotor function of the endothelium, and appearance of new cases of atrial fibrillation (AF) in patients with arterial hypertension with long-term treatment with lisinopril.Material and ...
V. I. Podzolkov +2 more
doaj +3 more sources
International Journal of Retina and Vitreous, 2018 Background and objectives The study investigated the intravitreal safety and vitreous disposition of lisinopril, an angiotensin converting enzyme inhibitor in rabbits for its projected use in retinopathy.
Madhu Nath +6 more
doaj +2 more sources
LISINOPRIL IMPLICATION IN THE CLINICAL PRACTICE
Рациональная фармакотерапия в кардиологии, 2016 The most socially significant cardiovascular diseases are recently considered from the standpoint of "cardiovascular continuum". Changes in neurohumoral factors especially activation of the renin-angiotensin-aldosterone system (RAAS) play a key role in ...
V. I. Podzolkov, A. I. Tarzimanova
doaj +3 more sources
ACE INHIBITORS IN ARTERIAL HYPERTENSION TREATMENT: FOCUS ON LISINOPRIL
Рациональная фармакотерапия в кардиологии, 2016 Approaches to the choice of antihypertensive pharmacotherapy are discussed. Evidence base of ACE inhibitor lisinopril is surveyed. Data about lisinopril effects on different endpoints, organoprotective action and advantages over other ACE inhibitors are ...
V. I. Podzolkov, K. K. Osadchy
doaj +5 more sources
Potential Nephrotoxicity of Lisinopril and Valsartan on Patients with Congestive Heart Failure
Pharmacology and Clinical Pharmacy Research, 2017 Lisinopril (angiotensin converting enzyme inhibitor) and valsartan (angiotensin II receptor blocker) are the first-line treatment for patients with congestive heart failure (CHF).
Sarini Pani +4 more
doaj +2 more sources
Evaluating the Educational Value of Artificial Intelligence in Pharmacotherapy Education. [PDF]
Pharmacol Res PerspectABSTRACT Final‐year medical students frequently make prescribing errors, partly because they have had insufficient training in therapeutic reasoning. Students need to understand the underlying rationale behind a drug choice in order to subsequently apply that knowledge critically and independently.
Hartjes MG +4 more
europepmc +2 more sources
Beta Blocker Toxicity at Therapeutic Doses: A Look Into Carvedilol Use in the Elderly. [PDF]
Clin Case RepABSTRACT Beta‐blocker toxicity does not occur only in overdose situations. In vulnerable populations such as children and the elderly, therapeutic doses may produce cumulative toxic effects similar to those seen in acute overdose. These patients require monitoring that extends beyond basic laboratory investigations to preempt cumulative toxicity.
Amo-Tachie S.
europepmc +2 more sources
COMPARSION BETWEEN RENOPROTECTIVE EFFECTS OF CARVEDILOL AND LISINOPRIL IN L-NAME-TREATED RATS [PDF]
Al-Azhar Journal of Pharmaceutical Sciences, 2012 Aim The present study compared the renoprotective effects of curative and prophylactic doses of carvedilol and lisinopril in L-NAME treated rats.
Amany Ibrahim
doaj +1 more source